Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics. [electronic resource] by
- Stoffel, E
- Maier, H
- Riedl, E
- Brüggen, M-C
- Reininger, B
- Schaschinger, M
- Bangert, C
- Guenova, E
- Stingl, G
- Brunner, P M
Producer: 20190923
In:
The British journal of dermatology vol. 178
Availability: No items available.
|
|
28.
|
Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial. [electronic resource] by
- Papp, K
- Thaçi, D
- Reich, K
- Riedl, E
- Langley, R G
- Krueger, J G
- Gottlieb, A B
- Nakagawa, H
- Bowman, E P
- Mehta, A
- Li, Q
- Zhou, Y
- Shames, R
Producer: 20160913
In:
The British journal of dermatology vol. 173
Availability: No items available.
|
|
29.
|
Carnosine treatment in combination with ACE inhibition in diabetic rats. [electronic resource] by
- Peters, V
- Riedl, E
- Braunagel, M
- Höger, S
- Hauske, S
- Pfister, F
- Zschocke, J
- Lanthaler, B
- Benck, U
- Hammes, H-P
- Krämer, B K
- Schmitt, C P
- Yard, B A
- Köppel, H
Producer: 20151229
In:
Regulatory peptides vol. 194-195
Availability: No items available.
|